Clinical trial
Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in…
NCT00162799 · J. Uriach and Company, Industry · Completed
Key facts
| NCT number | NCT00162799 |
|---|---|
| Title | Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human Obesity |
| Official title | Phase IIa Study of Triflusal in the Attenuation of Insulin Resistance in Men and Woman With Obesity |
| Lead sponsor | J. Uriach and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Insulin Resistance |
| Intervention type | Drug |
| Interventions | Triflusal (DCI) |
| Enrollment | 30 |
| Start date | Jul 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Sep 13, 2005 |
| Last update posted | Jun 23, 2006 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: